Publication | Closed Access

The combination of FDG PET and dynamic contrast-enhanced MRI improves the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy

EngineeringNeoadjuvant ChemotherapyMedical ImagingOncologic ImagingPet-mriBiomedical ImagingBreast ImagingDynamic Contrast-enhanced MriBreast CancerMri-guided Radiation TherapyRadiation OncologyOncologyMolecular ImagingFdg PetNuclear MedicineRadiologyHealth Sciences